Article Details
Retrieved on: 2019-05-13 18:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Alphabet-owned GV (formerly <b>Google Ventures</b>) has invested in Verve Therapeutics, a cardiovascular company developing gene editing therapies ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here